Nature Reviews' basic, translational and clinical content is written by internationally renowned basic and clinical academics and researchers and targeted towards readers in the biological and medical sciences, from postgraduate level upwards. While intended to be read by practising doctors, researchers and academics within a specialty, we aim to make all our articles accessible to readers working in any biological or medical discipline.In-depth Reviews present authoritative, up-to-date information on a topic, placing it in the context of a field's history and development. Topical discussion and opinions are proffered in Perspectives and News & Views articles, and in the Research Highlights section we filter primary research from a range of specialty and general medical journals.Subjects Covered:-Andrology-Benign prostatic hyperplasia-Biostatistics and clinical trials-Bladder cancer-Endourology and stones-Female urology-Fertility and infertility-Imaging and radiology-Infection-Inflammation-Pathology-Paediatric urology-Penile cancer-Prostate cancer-Renal cancer-Reproductive biology-Risk factors and epidemiology-Sexual dysfunction-Sexual psychology-Surgery-Testicular cancer-Transplantation-Trauma and reconstruction-Upper tract urothelial carcinoma-Upper urinary tract dysfunction-Urinary incontinence, urodynamics and lower urinary tract dysfunction-Urologic oncology.
《自然评论》的基础、翻译和临床内容由国际知名的基础和临床学者和研究人员撰写,面向生物和医学科学领域的研究生以上水平的读者。虽然我们的目标读者是专业领域内的执业医生、研究人员和学者,但我们的目标是让任何生物学或医学学科的读者都能阅读我们的所有文章。深入评论提供关于某个主题的权威、最新信息,并将其置于该领域的历史和发展背景下。主题: -男科学-良性前列腺增生-生物统计学和临床试验-膀胱癌-腔内泌尿科和结石-女性泌尿科-生育和不育-影像学和放射学-感染-炎症-病理学-儿科泌尿科-阴茎癌-前列腺癌-肾癌-生殖生物学-危险因素和流行病学-性功能障碍-性心理学-外科-睾丸癌-移植-创伤和重建-上尿路上皮癌-上尿路功能障碍-尿失禁、尿动力学和下尿路功能障碍-泌尿肿瘤学。
A new era: artificial intelligence and machine learning in prostate cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0193-3
Merging new-age biomarkers and nanodiagnostics for precision prostate cancer management
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0178-2
Molecular and histopathology directed therapy for advanced bladder cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0208-0
Long non-coding RNAs in genitourinary malignancies: a whole new world
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0195-1
The influence of BRCA2 mutation on localized prostate cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0164-8
Technologies for image-guided surgery for managing lymphatic metastases in prostate cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-018-0140-8
Harnessing the mesenchymal stem cell secretome for regenerative urology
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0169-3
Enzalutamide, apalutamide, or darolutamide: are apples or bananas best for patients?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0186-2
Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0220-4
Landmarks in vaginal mesh development: polypropylene mesh for treatment of SUI and POP
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0230-2
Ambulatory urodynamic monitoring: state of the art and future directions
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0175-5
Prostate cancer in sexual minorities and the influence of HIV status
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0194-2
Organ preservation in bladder cancer: an opportunity for truly personalized treatment
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0199-x
New approaches for effective and safe pelvic radiotherapy in high-risk prostate cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0213-3
Video review for measuring and improving skill in urological surgery
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-018-0138-2
Physical activity as an adjunct treatment for erectile dysfunction
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0210-6
IBD as a risk factor for prostate cancer: what is the link?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0157-7
Urogenital tuberculosis — epidemiology, pathogenesis and clinical features
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0228-9
First point-of-care PSA test for prostate cancer detection
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0179-1
Targeting DLL3 in neuroendocrine prostate cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0190-6
Health technology assessment methodology in metastatic renal cell carcinoma
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0257-4
Clinical decision-making with AR-V7
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0259-2
AR variants: lost in translation to clinical practice?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0204-4
18F-fluciclovine PET or PSMA PET for prostate cancer imaging?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0255-6
Prostate cancer: a tale of two sides
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0152-z
The Urology Care Foundation — trusted online resources in an era of misinformation
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0215-1
Testosterone in women: are we closing the gender gap?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0266-3
Neisseria gonorrhoeae resistance driven by antibiotic use
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0206-2
2019 ASCO Genitourinary Cancers Symposium
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0168-4
Combining options in metastatic prostate cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0217-z
Hyperpolarized MRI illustrates metabolic response to therapy
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-018-0139-1
Improving care to decrease stone recurrence and opioid use
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0275-2
Atezolizumab in understudied populations with bladder cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0200-8
To see or not to see — what renders prostate cancer visible?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0167-5
Budding prognostic technique for muscle-invasive bladder cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0187-1
Evolutionary and clinical trajectories of early-onset prostate cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0144-z
Barcelona! What a beautiful (therapeutic) horizon
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0177-3
Continence in nursing homes: a state of irreversible decline?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0172-8
AVPR1A: a target in CRPC?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0218-y
Emerging role for the unfolded protein response
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0156-8
First total penis, scrotum and abdominal wall transplant
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0265-4
Challenging beliefs of testosterone therapy and prostate cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0253-8
A new class of AR antagonists?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0147-9
Understanding clinical variables to improve empirical antibiotic therapy for UTI
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0240-0
Steaming ahead with BPH therapy
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0159-5
AR activity in treatment-naive prostate tumours
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0244-9
Genomic correlates of clinical outcomes
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0201-7
PSMA ADC shows promise in advanced disease
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0161-y
The perfect PARTNER: no HIV transmission with ART
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0205-3
Understanding obesity interactions with germ cell tumours
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0202-6